Last reviewed · How we verify
Bupropion-Naltrexone-Metformin
At a glance
| Generic name | Bupropion-Naltrexone-Metformin |
|---|---|
| Sponsor | WW International Inc |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial) (PHASE4)
- Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupropion-Naltrexone-Metformin CI brief — competitive landscape report
- Bupropion-Naltrexone-Metformin updates RSS · CI watch RSS
- WW International Inc portfolio CI